REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Neupharma, S. R. O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Advertising Agencies | All Other Business Support Services
Full name: Neupharma, S. R. O. Profile Updated: July 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Neupharma, S. R. O. is based in Slovakia. The head office is in Bratislava. It operates in the Pharmacies and Drug Stores industry. Neupharma, S. R. O. was incorporated on May 29, 2013. Neupharma, S. R. O. currently employs 5 - 9 (2025) people. There was a net sales revenue increase of 1.42% reported in Neupharma, S. R. O.’s latest financial highlights for 2024. Its’ total assets recorded a negative growth of 9.8%.

Headquarters
M. Sch. Trnavskeho, 8
Bratislava; Bratislavsky; Postal Code: 84101

Contact Details: Purchase the Neupharma, S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Neupharma, S. R. O. report to view the information.
Registered Capital:
Purchase the Neupharma, S. R. O. report to view the information.
Financial Auditors:
Purchase the Neupharma, S. R. O. report to view the information.
Incorporation Date:
May 29, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Neupharma, S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
1.42%▲
Total operating revenue
1.64%▲
Operating profit (EBIT)
2756.76%▲
EBITDA
96.49%▲
Net Profit (Loss) for the Period
N/A
Total assets
-9.8%▼
Total equity
3.84%▲
Operating Profit Margin (ROS)
3.11%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-33.33%▼
Quick Ratio
-0.06%▼
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo